Glucoset
Improving patient care by reducing the risk of death or complications associated with high or low blood sugar levels.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
* | €6.0m | Series A | |
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 33 % | (86 %) | - | - | 751 % | 374 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (13 %) | (731 %) | - | (16841 %) | (1054 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (14 %) | (809 %) | - | (20565 %) | (1559 %) | (277 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
More about Glucoset
EditDeveloper of a real-time intravascular blood glucose monitoring system designed to reduce harmful hypoglycemia. The company's system delivers continuous and accurate information on the patient's blood glucose level, enabling clinicians to make glucose control in ICUs possible and reduce mortality, complications, and costs.
Keywords: Healthcare Devices, Services, Supplies, Blood Glucose Level, Blood Glucose Meter, Glucose Control Equipment, Glucose Controlling Device, Glucose Leveling, Glucose Sensor, Monitor Glucose Level, Sensor Technology.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.